https://www.selleckchem.com/products/npd4928.html
Both of these patients had other manifestations of SLE. This gave an NPSLE prevalence of 1.5% (2/135) amongst patients with positive ANA, and 0.2% (2/911) amongst all patients who underwent testing for ANA. The prevalence of NPSLE in patients with psychosis and positive ANA was low at 1.5%. The low rate of clinically significant positive results would argue against routine testing for ANA in psychosis patients. The prevalence of NPSLE in patients with psychosis and positive ANA was low at 1.5%. The low rate of clinically significant pos
Like
Comment
Share
